ANGION BIOMEDICA CORP (ANGN)
US03476J1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to ANGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 53% above the current price.
ANGN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ANGN.
In the previous month the buy percentage consensus was at a similar level.
ANGN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-30 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-06-30 | Stifel | Downgrade | Buy -> Hold |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-10 | Oppenheimer | Maintains | Outperform |
| 2021-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-27 | Stifel | Maintains | Buy |
| 2021-03-02 | Oppenheimer | Initiate | Outperform |
| 2021-03-02 | Stifel | Initiate | Buy |
| 2021-03-02 | Cowen & Co. | Initiate | Outperform |
| 2021-03-01 | HC Wainwright & Co. | Initiate | Buy |